Anti-inflammatory activity of a polyphenolic enriched extract of Schima wallichii bark

Nat Prod Res. 2011 Apr;25(7):696-703. doi: 10.1080/14786410802560732. Epub 2009 Jul 31.

Abstract

In the present investigation, the anti-inflammatory activity of a polyphenolic enriched extract of Schima wallichii bark was evaluated in vitro using human peripheral blood mononuclear cells (PBMCs) and in vivo by carrageenan-induced paw oedema assay (acute study) and cotton pallet granuloma assay (chronic study). The extract exhibited significant inhibition of the production of tumour necrotic factor-α and interleukin-6 by PBMCs stimulated with lipopolysaccharide (LPS) in a concentration-dependent manner. The extract at the selected doses of 150 and 300 mg kg(-1) body weight p.o. exhibited significant dose-dependent anti-inflammatory responses, with 44.32 and 38.65% inhibition of inflammation in carrageenan-induced paw oedema and cotton pallet granuloma, respectively.

MeSH terms

  • Adult
  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use
  • Carrageenan / adverse effects
  • Edema / chemically induced
  • Edema / pathology
  • Edema / prevention & control
  • Granuloma / chemically induced
  • Granuloma / pathology
  • Granuloma / prevention & control
  • Humans
  • Inflammation / chemically induced
  • Inflammation / drug therapy
  • Interleukin-6 / antagonists & inhibitors
  • Leukocytes, Mononuclear / immunology
  • Lipopolysaccharides / pharmacology
  • Plant Bark / chemistry*
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use
  • Rats
  • Rats, Wistar
  • Theaceae / chemistry*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Young Adult

Substances

  • Anti-Inflammatory Agents
  • Interleukin-6
  • Lipopolysaccharides
  • Plant Extracts
  • Tumor Necrosis Factor-alpha
  • Carrageenan